Mr Janis earned undergraduate degrees in biochemistry and chemistry at Virginia Tech and an MS in toxicology at University of North Carolina. He has 2 decades of experience developing techniques for the analysis of pharmaceuticals and drugs of abuse. Current interests include high-throughput mass spectrometry screening techniques, as well as the identification and analysis of new and emerging drugs of abuse. He is a member of the American Society for Mass Spectrometry and the Society for Forensic Toxicologists.
Dr Grant earned a PhD in chromatographic and mass spectrometric technologies from the University of Swansea, Wales, United Kingdom. He continued his scientific training in various industrial settings, which have included senior scientist at GSK, principal scientist at Cohesive Technologies, technical director at Eli Lilly, and director of mass spectrometry at Esoterix Endocrinology.